Portfolio company
CurifyLabs
Finland · £10.2m raised
Raised
£10.2m
Latest stage
Series A
Rounds recorded
1
Backed by
6 investors
Sectors
About
CurifyLabs provides automated compounding systems and 3D printing technology for pharmacies and hospitals to manufacture personalised medicines for patients.
SourceFunding history · 1
Similar companies
Vitae
This company develops automated pharmaceutical compounding hardware and software for pharmacists to produce personalised oral medications.
Robotics-enabled personalized pharmaceuticals
Multiply Labs develops robotic clusters to automate the manufacturing of precision medicines and personalised cell therapies for pharmaceutical companies.
Carcinotech
Carcinotech manufactures 3D-bioprinted, patient-derived tumour models for drug developers and oncologists to perform rapid and ethical cancer drug testing and personalised medicine.
Limula
Limula develops an automated platform for manufacturing cell and gene therapies to assist therapy developers, hospitals and clinical centres with decentralized production.
hellomed
This company develops a digital medication management platform for care facilities, pharmacies and doctors to automate prescription workflows and reduce errors.
Closed Loop Medicine
This company develops software-drug combination products to provide personalised dosing and digital therapy for patients with chronic conditions and their clinicians.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
Sarcura
This company develops automated platforms for large-scale manufacturing of personalised cell therapies for the biopharmaceutical industry.
